AGENDA – NOVEMBER 7 – 9, 2019

7:00-7:10am
Welcome and Introduction
Ash Tewari, MBBS, MCh
7:10-7:45am
The Hans E. Shapira Lecture
Prostate Cancer: A Perspective; the Right Treatment for the Right Patient
at the Right Time
Joseph A. Smith, MD
EPIDEMIOLOGY, SCREENING AND DIAGNOSIS OF PROSTATE CANCER
7:45-8:00am
Epidemiology of Prostate Cancer
Prof. Olof Akre, MD, PhD
8:00-8:15am
Current Status of Prostate Cancer Screening: There is a Smarter Way
Quoc-Dien Trinh, MD
8:15-9:40am
9:40-9:50am
Q&A for Live Surgery
9:50-10:05am
Coffee Break (Courtesy of TBD)
10:05-10:35am
Genomics, Radiomics and Racial Disparities in Prostate Cancer
Ash Tewari, MBBS, MCh
10:35-10:50am
Racial Disparity in Prostate Cancer
TBD
10:50-11:05am
Biomarkers in Prostate Cancer: How Far Can the AR Lead Us?
Jun Luo, PhD
11:05-11:20am
Molecular Exploitation of Prostate Tumors for Targeted Therapies
John Isaacs, PhD
11:20-11:35am
Artificial Intelligence in Prostate Cancer Detection/Strategic Considerations
Rakesh Shiradkar, PhD
11:35-11:45am
Q & A
11:45-1:00pm
LUNCH
MAIN AFTERNOON SESSION
IMAGING AND BIOPSY IN PROSTATE CANCER
1:00-1:15pm
KEYNOTE: Clinical Trials of Neoadjuvant ADT and Immunotherapy for
Localized Prostate Cancer
J. Kellogg Parsons, MD
1:15-1:30pm
Confocal Fluorescence Digital Intraoperative Histopathological Imaging —
The Better Frozen Section?
Jorn H. Witt, MD
1:30-1:45pm
7TMRI Imaging in Prostate Cancer
Matthieu Durand, MD, MBBS
1:45-2:00pm
Learning After 12,000 Cases
Vipul Patel, MD, FACS
2:00-2:15pm
When to Skip Biopsy: Before Diagnosis, During AS, Follow-Up of FT
Prof. Arnauld Villers, MD, PhD
Q&A / Audience Response Question with App
IMMUNOTHERAPY AND PROSTATE CANCER
2:15-2:30pm
KEYNOTE:
Immunotherapy: Treatment of Patients with Lethal Disease
Padmanee Sharma, MD, PhD
2:30-2:45pm
Immunotherapy Strategies in Biochemically Recurrent Prostate Cancer
Ravi Madan, MD
2:45-3:00pm
Monitoring Predictive Biomarkers for Immunotherapy
Susan F. Slovin, MD, PhD
3:00-3:15pm
Immunotherapy for Prostate Cancer in a Neoadjuvant Setting
Sujit S. Nair, PhD
3:15-3:30pm
Audience Response Question with App/Coffee Break
3:30-3:40pm
Focal Therapy: Is It Ready for Prime Time?
Herbert Lepor, MD
3:40-3:50pm
Focal Therapy: New Nano Frontier
Art Rastinehad, DO
3:50-4:00pm
Partial Gland Ablation and Focal Therapy for Prostate Cancer
Jonathan Coleman, MD
4:00-4:10pm
The Role of Salvage Cryotherapy and the Outcomes
Aaron E. Katz, MD
4:10-4:20pm
The Role of Local Therapy in Oligometastatic PCa
Prof. Alexander Haese, MD
4:20-4:30pm
Pelvic Musculature and Innervation After Surgery
Thomas Bessede, MD, PhD
4:30-4:40pm
Global Perspectives in Robotic Surgery: A Healthy Market is a Competitive One
Prof. Maurizio Buscarini, MD, PhD, MPH-MBA
4:40-4:50pm
Complications of Robot-Assisted Laparoscopic Surgery Distant from the Surgical Site
Daniel Gainsburg, MD, MS
4:50-5:00pm
Treatment of Locally Recurrent Prostate Cancer After Whole Gland Cryotherapy
Using CyberKnife
Jonathan Haas, MD
5:00-5:10pm
RARP: Surgical Steps for Better Oncological and Functional Outcomes
Jorn H. Witt, MD
5:10-5:20pm
Management of Lymph Node-Positive Prostate Cancer and Neoadjuvant Systemic
Therapy in Localized Prostate Cancer
Brian F. Chapin, MD
5:20-5:30pm
Radical Prostatectomy in Oligometastatic Disease: Experience from the UK RCT
TRoMbone
Prasanna Sooriakumaran, MD, PhD, FRCS Urol, FEBU
5:30-5:40pm
Cytoreductive Radical Prostatectomy in Men with M1a or M1b Disease
Prof. Isaac Yi Kim, MD, PhD, MBA
5:40-5:50pm
Role of Surgery in Advanced Disease and Salvage Lymph Node Dissections
Vincent Laudone, MD
5:50-6:00pm
Positive Margins After RARP
Peter Wiklund, MD, PhD
6:00-6:05pm
BREAKOUT SESSION:
TARGETING THE TUMOR MICROENVIRONMENT (PART I)
1:00-1:15pm
Novel Therapeutic Impact of Tumor Microenvironment Targeting
Scott T. Tagawa, MD, MS, FACP
1:15-1:30pm
New Therapies for Castrate-Resistant Bone-Metastatic Prostate Cancer
Alexander Kirschenbaum, MD
1:30-1:45pm
Targeting DNA Repair Deficiency in Prostate Cancer
Joseph W. Kim, MD
1:45-2:00pm
Impact of Androgens on Response to Taxane Chemotherapy
Natasha Kyprianou, MBBS,PhD
2:00-2:15pm
Hormonal Control of Prostate Tumor Microenvironment
Alice C. Levine, MD
2:15-2:30pm
Same Old Sling? The Evolution of Perineal Sling Surgery for Treatment of
Post-Prostatectomy Incontinence
Neil H. Grafstein, MD
2:30-2:45pm
Quality of Life After Urologic Cancer
Gerardo J. Fernandez, MD
2:45-3:00pm
Treatment of Male Hypogonadism Using Non-Testosterone Therapies
Doron S. Stember, MD
3:00-3:15pm
Complications of Robot-Assisted Laparoscopic Surgery Distant from the Surgical Site
Reza Mehrazin, MD
3:15-3:30pm
Luminal Water Imaging for Noninvasive Characterization of Prostate Cancer Aggressiveness
Stefanie Hectors, PhD
3:30-3:45pm
Overcoming Challenges in Surgical Management of Prostate Cancer Patients
Jerry Blaivas, MD, FACS
3:45-4:00pm
Q & A
4:00-4:15pm
Metabolic Vulnerability of Prostate Cancer PTEN Inactivation
Ramon Parsons, MD, PhD
4:15-6:05pm
JOIN THE MAIN SESSION
7:00-7:10am
Day Two Welcome
Ash Tewari, MBBS, MCh
7:10-8:10am
Mind/Body Cancer Connection
Deepak Chopra, MD, FACP
8:10-9:40am
3D Live Surgery: Robot-Assisted Radical Prostatectomy
9:40-9:45am
Q&A (Live Surgery)
9:45-10:00am
Audience Response Question with App
BREAK / VISIT EXHIBITS
SURS – Panel Discussion
NAILING PROSTATE CANCER: WHICH TECHNIQUES, WHY, WHEN AND HOW?
10:00-10:15am
Value of 4K Score in Patients on Active Surveillance
Mitchell C. Benson, MD
10:15-10:30am
Robot-Assisted Radical Prostatectomy
Ash Tewari, MBBS, MCh
10:30-10:45am
Outpatient Single Port Extra Peritoneal RRP
Jihad Kaouk, MD
10:45-11:00am
Outpatient Prostatectomy
David Lee, MD, FACS
11:00-11:15am
“Peritoneal Scaffold” in Radical Prostatectomy
Mallikarjuna Chiruvella, MBBS, MS, MCh
11:15-11:30am
Retzius-Sparing Trans-Douglas Radical Prostatectomy
Markus Hohenfellner, MD
11:30-11:45am
3D Image-Guided Surgery in Prostate Cancer: From Cognitive to Augmented Reality Procedures
Prof. Francesco Porpiglia, MD
11:45-12:00pm
Less is More for Prostate Cancer
Prof. Abhay Rane, OBE
12:00-12:15pm
Radiotherapy and Impaired Intestinal Health – Lifelong Low-Grade Inflammation and the Role of Diet in Prevention
Prof. Gunnar N. Steineck, MD, PhD
12:15-12:30pm
Postoperative Opioid Use After Radical Prostatectomy
Misop Han, MD
12:30-12:45pm
Which Pre-treatment Risk Stratification Tool Predicts Best? Testing Predictive Performance in a Nationwide Population
Prof. Olof Akre, MD, PhD
12:45-1:45pm
LUNCH
MAIN AFTERNOON SESSION:
ADVANCED PROSTATE CANCER
Audience Response Question with App
1:45-2:00pm
Targeting Metabolic Alterations
Christopher J. Logothetis, MD
2:00-2:15pm
Surgical Management of Advanced Prostate Cancer
Ganesh Palapattu, MD, FACS
2:15-2:30pm
Medical Management of Metastatic Prostate Cancer
Simon Hughes, MBBS, FRCP, FRCR, MD (res), FHEA
2:30-2:45pm
Novel Therapeutics for Advanced Prostate Cancer
Ganesh Raj, MD, PhD
2:45-3:00pm
Recent Advances in Management of Advanced Prostate Cancer
William K. Oh, MD
3:00-3:15pm
Promising Clinical Trials in Prostate Cancer
Cora N. Sternberg, MD, FACP
3:15-3:30pm
PRINT Study: Therapeutic Impact So Far
Bobby Liaw, MD
3:30-3:40pm
Sexual Function After RALP
Doron S. Stember, MD
3:40-3:50pm
Emerging Treatment Options for Post-Prostatectomy Climacturia
Robert J. Valenzuela, MD, FACS
3:50-4:00pm
Treatment of Male Hypogonadism Using Non-Testosterone Therapies
Natan Bar-Chama, MD
4:00-4:10pm
Management of BPH in Active Surveillance Patients
Steven Kaplan, MD, FACS
AFTERNOON SESSION II:
INNOVATIONS IN URO-PATHOLOGY/ONCOLOGY
4:10-4:25pm
Keynote: Prostate Tumor Grading in 21st Century Patients
Jonathan I. Epstein, MD
4:25-4:40pm
Novel Metabolic Profiling in Advanced Prostate Cancer
Massimo Loda, MD
4:40-4:55pm
Targeting the Reactive Stroma
Gustavo E. Ayala, MD
4:55-5:10pm
Gene-Oncogene Interactions
Carlos Cordon-Cardo, MD, PhD
5:10-5:25pm
Castrate Resistant Prostate Cancer:
Therapeutic Targets from Metabolic and Genomic Profiles
Dimple Chakravarty, PhD
5:25-5:35pm
Awards Presentation and Closing Remarks
Ash Tewari, MBBS, MCh
6:30pm
Faculty Dinner (Details to come)
The Pierre New York, A Taj Hotel | 2 East 61st Street at Fifth Avenue
BREAKOUT SESSION:
Management of Prostate Cancer Patients/Quality of Life
2:00-2:15pm
Possible Application of Systematic Light Exposure to Treat Obese Frailty in Men with Advanced Stage Prostate Cancer
William H. Redd, PhD
2:15-2:30pm
Management of Incontinence After Radiation or Surgery
Rajveer S. Purohit, MD, MPH
2:30-2:45pm
Pre-Rehabilitation Interventions in Prostate Cancer Surgery
Bente Thoft Jensen, PhD, MPH
2:45-3:00pm
Impact of Smoking on Treatment Outcomes
Nihal Mohamed, PhD
3:00-3:15pm
Management of Prostate Cancer
Alexander Kirschenbaum, MD
3:15-3:30pm
Social Media Transforming Medicine
Nate Gross, MD
3:30-3:45pm
Urinary Adverse Events After Prostate Cancer Treatment (RP, RT, etc.)
Jaspreet S. Sandhu, MD
3:45-4:00pm
Teamwork and Safety Conversations to Prevent Wrong Site Surgery
Amanda Rhee, MD, MS
4:00-5:35pm
JOIN THE MAIN SESSION
KIDNEY AND BLADDER CANCER
In Collaboration with Society of Urologic Robotic Surgeons
and Endourological Society
7:00-7:10am
DAY THREE WELCOME Stern Auditorium
Ketan K. Badani, MD
7:10-7:25am
Contemporary Management of Upper Tract Urothelial Cancer
Jonathan Coleman, MD
7:25-7:35am
Endoscopic Management
Mantu Gupta, MD, FRCS
7:35-7:45am
Radical Nephroureterectomy with Robotic Assistance: Should it be Standard Care?
Ashok Hemal, MD, MCh, FACS, FRCS
7:45-7:55am
Optimal Management of Bladder Cuff
Mihir Desai, MD
7:55-8:10am
Firefly and Upper Tract Reconstruction
Daniel Eun, MD
8:10-8:15am
Q&A/Audience Response Question with App
8:15-8:30am
Optimizing Robotic Partial Nephrectomy Outcome:
Lessons Learned Over 1,000 Procedures
Ketan K. Badani, MD
8:30-8:45am
Is There a Role for Partial Nephrectomy in Benign Tumors?
Ithaar H. Derweesh, MD
8:45-8:55am
Robotic Partial Nephrectomy: The Italian Experience
Umberto Capitanio, MD
8:55-9:05am
Robotic Partial Nephrectomy: The Asia/Japan Experience
Ryoichi Shiroki, MD, PhD
9:05-9:15am
Optimizing the Retroperitoneal Approach
James Porter, MD
9:15-9:30am
Lessons on Medical Leadership
Ralph V. Clayman, MD, MBA
9:30-9:40am
Robotic Surgery in Kidney Transplant World
Michael A. Palese, MD
9:40-9:45am
Q&A
9:45-10:00am
BREAK / VISIT EXHIBITS
11:15-11:50am
DEBATE: Single Port Surgery for Kidney
11:50-12:00pm
3-D Imaging Applications for Robotic Surgery: Evaluation of Surgeons’ Perceptions
Prof. Francesco Porpiglia, MD
12:00-1:00pm
LUNCH
1:00-1:10pm
SURS President Welcome Address
Jihad Kaouk, MD
1:10-1:20pm
Establishing Office-Based Renal Mass Biopsy: An Update on Outcome
Jaime Landman, MD
1:20-1:35pm
Robotic Partial Nephrectomy for T1b/T2a Renal Masses: Are We Overdoing It?
Brian Shuch, MD
1:35-1:45pm
Renal Function After Partial Nephrectomy –
Is Renal Ischemia, Volume Preservation, or Both Equally Important?
Dipen Parekh, MD
1:45-1:55pm
Selective Clamping: Update on Outcomes and Data
Michael Stifelman, MD
1:55-2:10pm
The Role of Robotic Radical Nephrectomy
Ketan K. Badani, MD
2:10-2:25pm
DEBATE: Is There Still a Role for Cytoreductive Surgery in Advanced Renal Cell
Carcinoma?
2:25-2:30pm
Audience Response Question with App / BREAK
2:30-4:55pm
CONCURRENT 10 MINUTE LECTURES
New Clinical Trial Designs in Urothelial Carcinoma
Bishoy Morris Faltas, MD
Zero Narcotic Protocol for Robotic Cystectomy: Surgical and Anesthesia Considerations
John Sfakianos, MD Alan Sim, MD
Standardizing Training with a “Top Down Approach”: Conclusions from a
Train the Trainer Delphi Process
Justin Collins, MBChB, MD, FRCS
Intracorporeal Urinary Diversion for Robotic Radical Cystectomy
Alvin Goh, MD
Do All Patients with Muscle Invasive Bladder Cancer Require Neoadjuvant Chemotherapy? A Review of Evidence
Hugh Lavery, MD
4:55-5:00pm
End of Symposium Conclusion
Ash Tewari, MBBS, MCh